Development and initial validation of the Cognitive Change Scale (CCS)
Multiple Sclerosis Journal · 2024
DOI: 10.1177/13524585241290102 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Multiple Sclerosis Journal, 2024. Verfasst von Anne Kever und 3 weiteren Autor:innen. Beteiligte Einrichtung: St. Michael's Hospital, Barlo Multiple Sclerosis Centre, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Cognitive impairment is common in neurologic diseases. Precise measurement of cognitive change over time is necessary for isolating disease-related patterns from normal age-related decline. Existing measures of subjective cognition, however, focus on present status. There is, to our knowledge, no currently available self-report measure of cognitive change. We therefore developed the Cognitive Change Scale (CCS), which assesses perceived cognitive change in neurologic populations.
Methods
A systematic mixed-methods process was followed for the scale design and validation. Associations of CCS responses to demographics, mood, and fatigue were examined in 131 persons with multiple sclerosis. A total of 46 participants also completed a cognitive test battery. Correlations of test scores with CCS responses were calculated.
Results
The 17-item CCS showed good reliability and validity. Results of exploratory and confirmatory factor analyses supported a four-factor structure, with items reflecting change in (1) general cognition, (2) language and executive function, (3) external feedback, and (4) use of coping strategies. Positive relationships of CCS scores with fatigue, depression, and anxiety were observed. Correlations of CCS scores with cognitive test performance did not reach significance.
Conclusion
The CCS may be a useful cognitive outcome tool for treatment trials in neurologic populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St. Michael's Hospital, Barlo Multiple Sclerosis Centre, Toronto, ON, Canada.
- Cognitive Neuroscience Division, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
ORCID-Profile: Anne Kever, Leila Simani, Victoria M Leavitt
Zitieren
APA
Kever, A., Heuer, L. B., Simani, L., & Leavitt, V. M. (2024). Development and initial validation of the Cognitive Change Scale (CCS). Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241290102
Vancouver
Kever A, Heuer LB, Simani L, Leavitt VM. Development and initial validation of the Cognitive Change Scale (CCS). Multiple Sclerosis Journal. 2024. doi:10.1177/13524585241290102
BibTeX
@article{Kever2024,
author = {Kever, Anne and Heuer, Lauren B and Simani, Leila and Leavitt, Victoria M},
title = {Development and initial validation of the Cognitive Change Scale (CCS)},
journal = {Multiple Sclerosis Journal},
year = {2024},
doi = {10.1177/13524585241290102}
}
EUVIMED